Germany Allergy Therapeutics Market Report 2022 to 2030

Germany Allergy Therapeutics Market Analysis

$ 3999

Germany Allergy Therapeutics Market was valued at $849 Mn in 2022 and is estimated to reach $1217 Mn in 2030, exhibiting a CAGR of 4.6% during the forecast period. The growing demand for pharmaceutical allergy therapeutics is being driven by the rising incidence of allergic diseases and associated health issues. The major pharmaceutical companies that are presently performing in the market are Novartis, GlaxoSmithKline (GSK), Sanofi, Roche, Merck & Co., Johnson & Johnson, AstraZeneca, Bayer, Boehringer Ingelheim and Allergan

ID: IN10DEPH429 CATEGORY: Pharmaceuticals GEOGRAPHY: Germany AUTHOR: Medha Sansanwal

Buy Now

Germany Allergy Therapeutics Market Executive Summary

Germany Allergy Therapeutics Market was valued at $849 Mn in 2022 and is estimated to reach $1217 Mn in 2030, exhibiting a CAGR of 4.6% during the forecast period.

Allergens are substances from the environment that, in certain cases, trigger an immunological reaction. Dust mites, pollen, mold, and specific foods like milk, eggs, soy, and almonds are examples of common allergies. From minor symptoms like a runny nose and itchy eyes to severe ones like anaphylaxis, which can result in breathing problems and unconsciousness, allergic responses can take many different forms. Immunotherapy, avoiding allergens, and using prescription drugs, including antihistamines and nasal corticosteroids, are some of the available treatment options.

About 8% of adult Germans today have bronchial asthma, which includes allergic asthma. Furthermore, allergies account for roughly one-third of adult cases (31%), encompassing hay fever, skin or eye allergies, food allergies, and other allergens (apart from allergic asthma). Compared to men, women reported a higher frequency of allergy disorders.Allergy to hay fever was diagnosed in about 16% of individuals, making allergic rhinitis the most common allergy condition. The lifetime incidence of bronchial asthma is roughly 9%, and the prevalence of allergic contact dermatitis in adults is also approximately 9%. Food allergies (5%), atopic dermatitis (4%), and insect venom allergy (3%), on the other hand, are less common and more commonly affect women than males.

IgE antibodies specific to environmental allergens were identified in 50% of Germany's adult population. There was variation in the rates of sensitization: 34% were sensitized to a combination of inhaled allergens, 26% to food allergens, 19% to pollen from grass and trees, and 11% to pollen from herbs. The prevalence of hay fever in children and adolescents is 11%, while bronchial asthma affects 6% of the population. Females had a greater lifetime prevalence of atopic dermatitis (13%), but boys received bronchial asthma diagnoses more often. Between 14% and 37% of children and adolescents reported being sensitized, with boys typically exhibiting higher rates than girls.The German population has a high prevalence of allergy disorders and sensitization, which highlights the necessity for ongoing research and practical treatment techniques to address these health concerns.

The development of sublingual immunotherapy (SLIT), an oral form of allergy immunotherapy (AIT), is being driven by German research institutes and pharmaceutical companies. Comparing SLIT to subcutaneous immunotherapy, recent research shows encouraging results in the treatment of pollen allergies, with possible benefits including reduced side effects and improved patient compliance.

Market Dynamics

Market Growth Drivers

Prevalence of Allergies: The rising incidence of allergies, particularly environmental allergies and respiratory allergies like hay fever, is driving the need for efficient allergy treatment medications. Urbanization and environmental changes are two factors that may be contributing to an increase in the prevalence of allergies.

Rising Awareness and Diagnosis: An increasing number of cases are being diagnosed as a result of growing awareness of allergies and improvements in diagnostic tools. People are more inclined to seek out pharmacological and medical interventions for their allergy problems as awareness increases.

Aging Population: There is a growing probability that people may experience allergies or acquire new allergies as they become older, which fuels the ongoing need for allergy medications. The range of allergic disorders is wide, and the prevalence of allergic diseases in the elderly population is high and growing. Due to their aging immune systems, which may find it more difficult to fend off minor allergic reactions to triggers like pollen, the elderly are more vulnerable to the symptoms of allergies.

Market Restraints

High Cost of Treatment: Due to their exorbitant cost, many of the most successful current allergy therapies, such as biologics and sublingual immunotherapy, are out of reach for a significant portion of the population. This financial barrier can restrict the market's adoption of these medications and keep patients from getting the best care available.

Treatment Compliance and Adherence: The efficacy of allergy medications, particularly immunotherapy therapies, depends on patients' continuous adherence to extended treatment plans. Obstacles like exorbitant expenses, complexity, or unsatisfactory outcomes resulting in insufficient patient compliance may reduce the effectiveness of treatment and hinder market growth.

Cultural and Behavioural Factors: Market penetration may be hampered by certain groups preference for traditional medications or home cures over contemporary treatments. Decreased awareness within a community could make it harder to identify and comprehend allergy symptoms, which would postpone diagnosis and treatment. Notwithstanding these difficulties, there is rising interest in the use of non-pharmaceutical strategies, such as air filters, to reduce allergens and/or avoid allergy symptoms.

Notable Recent Updates

October 2023, German generic drug specialist Dermapharm purchased Merck KGaA's Allergopharma division, which included a production facility and a range of therapeutic and diagnostic treatments for treating type 1 allergies, such as hay fever.

Healthcare Policies and Regulatory Landscape

The Federal Ministry of Health (BMG), which is in charge of creating national healthcare policies, and the Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM), which is in charge of primary regulatory oversight for drug approvals and guarantees safety, efficacy, and quality, are the key organizations in Germany that coordinate healthcare policies and regulatory oversight pertaining to allergy treatment drugs. In particular, the regulatory environment pertaining to biomedicines is influenced by the Paul-Ehrlich-Institute (PEI). The German Medicines Agency (AMB) works with partners to conduct drug surveillance, and the Institute for Quality and Efficiency in Health Care (IQWiG) evaluates the risks and benefits of medical therapies. Different Health Technology Assessment (HTA) committees assess the value and cost-effectiveness of healthcare interventions, and the Federal Joint Committee (G-BA) has an impact on reimbursement choices. Drug pricing talks involve the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband). According to European Medicines Agency rules, this regulatory system requires enterprises to go through rigorous processes for clearance and compliance before market authorization and reimbursement considerations are handled

Competitive Landscape

Key Players

Novartis
GlaxoSmithKline (GSK)
Sanofi
Roche
Merck & Co.
Johnson & Johnson
AstraZeneca
Bayer
Boehringer Ingelheim
Allergan

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Germany Allergy Therapeutics Market Segmentation

By Treatment Type

Anti-allergy drugs
Immunotherapy

By Type of Allergy

Eye allergy
Asthma
Skin allergy
Food allergies
Rhinitis
Other allergy types

By Route of Administration

Oral
Inhalers
Intranasal
Other routes of administration

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies
Other distribution channel

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.